Advertisement

Index by author

July 01, 1991; Volume 40,Issue 1

A

  1. Ahluwalia, G S

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

  2. Azuma, M

    1. Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

B

  1. Baden, H A

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

  2. Baron, J

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

  3. Beaune, P H

    1. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

  4. Binder, T P

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

  5. Broder, S

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

  6. Bruinvels, A

    1. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;

C

  1. Charleson, P

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  2. Clifford, D B

    1. Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
      C F Zorumski, L L Thio and D B Clifford
      Molecular Pharmacology July 1991, 40 (1) 45-51;

  3. Coffman, B

    1. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;

  4. Coon, M J

    1. Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;

  5. Cooney, D A

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

  6. Cooper, C L

    1. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
      R A Jeffs, C L Cooper and T K Harden
      Molecular Pharmacology July 1991, 40 (1) 85-92;

D

  1. Ding, X X

    1. Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;

  2. Dissanayake, V U

    1. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
      V U Dissanayake, J Hughes and J C Hunter
      Molecular Pharmacology July 1991, 40 (1) 93-100;

  3. Duffel, M W

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

E

  1. Eichelbaum, M

    1. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;

  2. Evans, J F

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

F

  1. Fischer, C

    1. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;

  2. Fortin, R

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  3. Fridland, A

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

G

  1. Gauthier, J Y

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  2. Ged, C

    1. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

  3. Gerfen, C R

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  4. Gonzalez, F J

    1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

  5. Green, M

    1. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;

  6. Guengerich, F P

    1. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

H

  1. Hamano, S

    1. Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

  2. Harden, T K

    1. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
      R A Jeffs, C L Cooper and T K Harden
      Molecular Pharmacology July 1991, 40 (1) 85-92;

  3. Hartman, N R

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

  4. Hibert, M F

    1. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;

  5. Hoflack, J

    1. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;

  6. Hosie, L

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

  7. Hughes, J

    1. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
      V U Dissanayake, J Hughes and J C Hunter
      Molecular Pharmacology July 1991, 40 (1) 93-100;

  8. Hunter, J C

    1. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
      V U Dissanayake, J Hughes and J C Hunter
      Molecular Pharmacology July 1991, 40 (1) 93-100;

I

  1. Inaba, T

    1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

J

  1. Jaiswal, N

    1. Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
      N Jaiswal, R K Jaiswal and K U Malik
      Molecular Pharmacology July 1991, 40 (1) 101-106;

  2. Jaiswal, R K

    1. Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
      N Jaiswal, R K Jaiswal and K U Malik
      Molecular Pharmacology July 1991, 40 (1) 101-106;

  3. Jeffs, R A

    1. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
      R A Jeffs, C L Cooper and T K Harden
      Molecular Pharmacology July 1991, 40 (1) 85-92;

  4. Johns, D G

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

K

  1. Kageyama, S

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

  2. Kalow, W

    1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

  3. Kim, S G

    1. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;

  4. Knapp, S A

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

  5. Kroemer, H K

    1. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;

L

  1. Lauriault, V V

    1. Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol.
      V V Lauriault and P J O'Brien
      Molecular Pharmacology July 1991, 40 (1) 125-134;

  2. Lévillé, C

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  3. Li, M

    1. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

M

  1. MacIntyre, D E

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  2. Mahan, L C

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  3. Malik, K U

    1. Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
      N Jaiswal, R K Jaiswal and K U Malik
      Molecular Pharmacology July 1991, 40 (1) 101-106;

  4. Mancini, J A

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  5. McVittie, L D

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  6. Meese, C O

    1. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
      H K Kroemer, C Fischer, C O Meese and M Eichelbaum
      Molecular Pharmacology July 1991, 40 (1) 135-142;

  7. Mitsuya, H

    1. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
      N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
      Molecular Pharmacology July 1991, 40 (1) 118-124;

  8. Monsma, F J

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  9. Morita, K

    1. Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

N

  1. Nakata, H

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  2. Nickolson, V J

    1. Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
      S W Tam, D Rominger and V J Nickolson
      Molecular Pharmacology July 1991, 40 (1) 16-21;

  3. Niznik, H B

    1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

  4. Novak, R F

    1. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;

O

  1. O'Brien, P J

    1. Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol.
      V V Lauriault and P J O'Brien
      Molecular Pharmacology July 1991, 40 (1) 125-134;

  2. Oka, M

    1. Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

P

  1. Pachter, J A

    1. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
      J A Pachter
      Molecular Pharmacology July 1991, 40 (1) 107-111;

  2. Peng, H M

    1. Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;

  3. Porter, T D

    1. Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
      H M Peng, T D Porter, X X Ding and M J Coon
      Molecular Pharmacology July 1991, 40 (1) 58-62;

  4. Prasit, P

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  5. Puig, J

    1. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;

R

  1. Reddy, S L

    1. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;

  2. Rominger, D

    1. Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
      S W Tam, D Rominger and V J Nickolson
      Molecular Pharmacology July 1991, 40 (1) 16-21;

S

  1. Sanders, J A

    1. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
      M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
      Molecular Pharmacology July 1991, 40 (1) 36-44;

  2. Sibley, D R

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  3. Smyk-Randall, E M

    1. Cloning and expression of an A1 adenosine receptor from rat brain.
      L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
      Molecular Pharmacology July 1991, 40 (1) 1-7;

  4. Srivastava, P K

    1. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

  5. States, J C

    1. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
      S G Kim, S L Reddy, J C States and R F Novak
      Molecular Pharmacology July 1991, 40 (1) 52-57;

  6. Styczynski, P

    1. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;

  7. Sunahara, R

    1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

T

  1. Tam, S W

    1. Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
      S W Tam, D Rominger and V J Nickolson
      Molecular Pharmacology July 1991, 40 (1) 16-21;

  2. Tephly, T

    1. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
      P Styczynski, M Green, J Puig, B Coffman and T Tephly
      Molecular Pharmacology July 1991, 40 (1) 80-84;

  3. Teraoka, K

    1. Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Azuma, M Oka and S Hamano
      Molecular Pharmacology July 1991, 40 (1) 112-117;

  4. Thérien, M

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  5. Thio, L L

    1. Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
      C F Zorumski, L L Thio and D B Clifford
      Molecular Pharmacology July 1991, 40 (1) 45-51;

  6. Trumpp-Kallmeyer, S

    1. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
      M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
      Molecular Pharmacology July 1991, 40 (1) 8-15;

  7. Tyndale, R F

    1. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
      R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
      Molecular Pharmacology July 1991, 40 (1) 63-68;

W

  1. Wall, S J

    1. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

  2. Wellstein, A

    1. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

  3. Wolfe, B B

    1. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

Y

  1. Yasuda, R P

    1. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
      M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
      Molecular Pharmacology July 1991, 40 (1) 28-35;

  2. Yun, C H

    1. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
      P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
      Molecular Pharmacology July 1991, 40 (1) 69-79;

Z

  1. Zamboni, R

    1. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
      J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
      Molecular Pharmacology July 1991, 40 (1) 22-27;

  2. Zorumski, C F

    1. Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
      C F Zorumski, L L Thio and D B Clifford
      Molecular Pharmacology July 1991, 40 (1) 45-51;
Back to top

In this issue

Advertisement